NYXH — Nyxoah SA Share Price
- €201.36m
- €138.46m
- €4.52m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.78 | ||
Price to Tang. Book | 3.2 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 44.54 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -42.96% | ||
Return on Equity | -56.07% | ||
Operating Margin | -1300.8% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 0.07 | 0.85 | 3.08 | 4.35 | 4.52 | 19.46 | 57.68 | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 14th, 2009
- Public Since
- September 18th, 2020
- No. of Employees
- 184
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Euronext - Brussels
- Shares in Issue
- 37,427,265

- Address
- Rue Edouard Belin 12, MONT-SAINT-GUIBERT, 1435
- Web
- https://www.nyxoah.com/
- Phone
- +32 26121755
- Auditors
- Ernst & Young Bedrijfsrevisoren BCV
Latest News for NYXH
Upcoming Events for NYXH
Q1 2025 Nyxoah SA Earnings Release
Nyxoah SA Annual Shareholders Meeting
Q2 2025 Nyxoah SA Earnings Release
Similar to NYXH
Agfa Gevaert NV
Euronext - Brussels
Biocartis NV
Euronext - Brussels
Ion Beam Applications SA
Euronext - Brussels
Onward Medical NV
Euronext - Brussels
FAQ
As of Today at 22:23 UTC, shares in Nyxoah SA are trading at €5.38. This share price information is delayed by 15 minutes.
Shares in Nyxoah SA last closed at €5.38 and the price had moved by -42.4% over the past 365 days. In terms of relative price strength the Nyxoah SA share price has underperformed the FTSE Global All Cap Index by -43.84% over the past year.
The overall consensus recommendation for Nyxoah SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreNyxoah SA does not currently pay a dividend.
Nyxoah SA does not currently pay a dividend.
Nyxoah SA does not currently pay a dividend.
To buy shares in Nyxoah SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €5.38, shares in Nyxoah SA had a market capitalisation of €201.36m.
Here are the trading details for Nyxoah SA:
- Country of listing: Belgium
- Exchange: BRU
- Ticker Symbol: NYXH
Based on an overall assessment of its quality, value and momentum Nyxoah SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Nyxoah SA is €12.60. That is 134.2% above the last closing price of €5.38.
Analysts covering Nyxoah SA currently have a consensus Earnings Per Share (EPS) forecast of -€1.82 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nyxoah SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -40.96%.
As of the last closing price of €5.38, shares in Nyxoah SA were trading -35.32% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Nyxoah SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €5.38.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Nyxoah SA's directors